Kang Seung-gi, who once faced near‑bankruptcy after debt linked to a 30‑carat, press‑described “Ronaldo‑sized” diamond, has emerged as a pioneer in South Korea’s lab‑grown diamond industry. The turnaround — from a single large‑carat exposure to a business built around cultivated diamonds — reframes risk and opportunity for suppliers and retailers watching shifts in sourcing and price positioning.
- Gem: Diamond (30‑carat referenced)
- Situation: Near‑bankruptcy tied to a large natural gem; subsequent pivot to lab‑grown diamond production/commerce
- Region: South Korea (pioneering role identified)
- Market angle: Lab‑grown diamond sector and downstream retail implications
Context: lab‑grown momentum and the risk of large‑carat exposure
Large‑carat inventories carry acute capital risk: a single 30‑carat lot can tie up liquidity and concentrate valuation risk in one SKU. Kang’s experience underscores that vulnerability, and it also highlights the strategic advantage of vertically integrated lab‑grown supply. Cultivated diamonds reduce dependence on mined‑stone cadence and offer tighter cost control across color, clarity and carat bands — attributes retailers prize when managing margins and assortment breadth.
Technically, lab‑grown product allows more predictable outcomes on cut and color distribution, removing some of the stochasticity inherent to large natural stones. That predictability supports design approaches that favor open‑backed settings, knife‑edge shanks for large solitaires, or micro‑pavé halos that rely on consistent small‑stone inventories. In markets leaning toward quiet luxury, the tactile cues — substantial heft, vitreous luster and satin‑finished mounting — matter as much as origin claims and price per carat.
Impact: what this means for the US market
For US retailers and wholesalers the takeaways are operational and strategic. Operationally, lab‑grown suppliers emerging from markets such as South Korea expand sourcing options and can compress lead times for replenishment of high‑turn SKUs. That reduces the need to carry single high‑ticket, high‑risk natural stones that can strain cash flow.
Strategically, Kang’s pivot signals pressure on the traditional natural‑diamond premium at accessible and bridal price points. Merchants should reassess assortment mixes: increase lab‑grown SKUs where margin resiliency and predictable quality are priorities, while selectively curating natural large‑carat pieces as investment or halo inventory that justifies a premium. Marketing should focus on provenance, technical craft (growth method, post‑growth finishing) and product feel — satin‑finished gold, precise knife‑edge settings, or micro‑pavé workmanship — rather than hyperbolic storytelling.
Investors and category managers will watch two vectors: whether South Korean lab‑grown players scale into meaningful export supply, and whether that expanded supply narrows price gaps across carat bands. Both outcomes would change stocking strategies in the US — from occasional showpieces to programmable, margin‑stable staples — and reduce the financial concentration risk demonstrated by a single 30‑carat exposure.
In short, Kang Seung‑gi’s story is a case study in how a costly natural‑stone position can catalyze a move to controlled, lab‑grown production — a move that matters to anyone managing inventory, margin or brand credibility in today’s diamond market.
Image Referance: https://www.chosun.com/english/kpop-culture-en/2026/03/25/W6CP5YL4CRD3BMXGVABU5KGG4E/